Major League Baseball has suspended Atlanta Braves outfielder and designated hitter Jurickson Profar for 162 games following a second positive test for performance-enhancing drugs. The suspension, announced Tuesday by the Commissioner's Office, effectively ends Profar’s 2026 season before it could truly begin. The 33-year-old All-Star tested positive for exogenous testosterone and its metabolites, a direct violation of MLB's Joint Drug Prevention and Treatment Program.
This penalty marks a significant escalation from his previous offense. Under the league's strict drug policy, a second violation triggers an automatic full-season ban without pay. Consequently, Profar will forfeit his entire $15 million salary for the 2026 campaign and is deemed ineligible for the postseason, should the Braves qualify. The suspension also bars him from participating in the upcoming World Baseball Classic, where he was slated to represent Team Netherlands. For an Atlanta team already navigating early spring injuries, losing a key middle-of-the-order bat is a devastating blow.
A Career Derailed: The Second Positive Test
The announcement sent shockwaves through the Grapefruit League, particularly given the timing. Profar was attempting to rebuild his reputation after an 80-game suspension in 2025 for testing positive for Chorionic Gonadotropin (hCG). That first violation cost him half of his debut season with Atlanta. Now, less than a year later, a second positive test for a more severe substance—exogenous testosterone—has placed his future in Major League Baseball in serious jeopardy.
MLB’s drug policy is rigid regarding repeat offenders. While a first offense warrants an 80-game ban, a second offense escalates to 162 games, and a third results in a lifetime ban. Profar’s suspension is effective immediately. Although the Major League Baseball Players Association (MLBPA) has indicated it will file a grievance on Profar’s behalf, historical precedents suggest that overturning a suspension based on a positive sample for synthetic testosterone is exceptionally difficult. The strict liability standard means players are responsible for what is in their bodies, regardless of intent.
Financial and Roster Fallout for the Braves
The financial implications for Jurickson Profar are massive. He signed a three-year, $42 million contract with the Braves in January 2025, hoping to capitalize on a career-best 2024 season. Instead, he will have surrendered nearly $21 million in salary across 2025 and 2026 due to suspensions. For the Braves organization, the immediate relief of not paying his $15 million salary this year is overshadowed by the roster hole his absence creates.
Atlanta’s front office must now pivot quickly. Profar was projected to serve primarily as the designated hitter and provide crucial depth for the outfield. His switch-hitting ability and veteran presence were expected to balance a lineup that leans right-handed. With him removed from the equation, the pressure mounts on the remaining core to stay healthy and productive.
Braves Outfield Depth 2026: Who Steps Up?
The Braves outfield depth 2026 chart now undergoes a forced reshuffle. The starting trio remains formidable, with Ronald Acuña Jr. in right field, Michael Harris II patrolling center, and offseason acquisition Mike Yastrzemski in left. However, the safety net is gone. The loss of Profar exposes the team's lack of experienced depth.
Internal options to fill the void include Eli White, who offers elite speed and defense but lacks Profar's offensive ceiling, and non-roster invitees like Dom Smith, who could see increased at-bats at DH. The injury to infielder Ha-Seong Kim—who might have absorbed some DH at-bats—further complicates the puzzle. General Manager Alex Anthopoulos may be forced to explore the late free-agent market or trade block to find a reliable bat, as the internal replacements currently project as below-league-average hitters.
Impact on the 2026 Season and Beyond
This suspension casts a long shadow over the Braves' 2026 aspirations. In a competitive National League East, the margin for error is slim. Losing a projected 2.0-3.0 WAR player for zero compensation on the field forces Atlanta to rely heavily on their pitching staff, which is already dealing with its own injury concerns, including elbow issues for young starters like Spencer Schwellenbach.
For Profar, the road back will be arduous. He will be 34 years old when he is eligible to return in 2027, having missed a year and a half of competitive baseball over a three-season span. Teams are historically hesitant to commit roster spots to aging players with a history of PED violations. This second strike essentially wipes out his prime earning years and leaves his legacy in the sport permanently tarnished.
The Braves released a brief statement expressing their "incredible disappointment" and reiterating their support for MLB's Joint Drug Prevention and Treatment Program. As the team prepares for Opening Day without their projected cleanup hitter, the focus shifts to whether this talented but thinned roster can withstand the attrition of a 162-game season.
